FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17440711000001101: Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60364301000001113 Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60364401000001117 Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Is a Fluticasone 125micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Is a Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler false Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has active ingredient Salmeterol true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Inhaler false Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Is a Seretide Evohaler true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Is a Fluticasone 125micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) 120 dose Has AMP True Seretide 125 Evohaler (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start